Published in Nephrol Dial Transplant on July 02, 2012
Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study. Nephrol Dial Transplant (2012) 0.94
Vascular calcification: When should we interfere in chronic kidney disease patients and how? World J Nephrol (2016) 0.78
Standardized Outcomes in Nephrology-Transplantation: A Global Initiative to Develop a Core Outcome Set for Trials in Kidney Transplantation. Transplant Direct (2016) 0.77
Different in vitro proliferation and cytokine-production inhibition of memory T-cell subsets after calcineurin and mammalian target of rapamycin inhibitors treatment. Immunology (2016) 0.77
Vascular calcification, bone and mineral metabolism after kidney transplantation. World J Transplant (2015) 0.75
Cancer-related outcomes in kidney allograft recipients in England versus New York State: a comparative population-cohort analysis between 2003 and 2013. Cancer Med (2017) 0.75
Factors influencing survival after kidney transplant failure. Transplant Res (2014) 0.75
Comparing kidney transplant outcomes; caveats and lessons. Nephrol Dial Transplant (2012) 0.75
Dialysis Vintage and Outcomes after Kidney Transplantation: A Retrospective Cohort Study. Clin J Am Soc Nephrol (2016) 0.75
Current evidence on vitamin D deficiency and kidney transplant: What's new? Rev Endocr Metab Disord (2017) 0.75
Toward Establishing Core Outcome Domains For Trials in Kidney Transplantation: Report of the Standardized Outcomes in Nephrology-Kidney Transplantation Consensus Workshops. Transplantation (2017) 0.75
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (2007) 20.57
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69
Barriers to cadaveric renal transplantation among blacks, women, and the poor. JAMA (1998) 5.10
Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med (2006) 4.79
Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int (2002) 3.79
Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol (2003) 3.53
Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation (2004) 2.26
Racial differences in the survival of cadaveric renal allografts. Overriding effects of HLA matching and socioeconomic factors. N Engl J Med (1992) 2.09
Mortality after kidney transplantation: a comparison between the United States and Canada. Am J Transplant (2006) 1.92
Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol (2000) 1.90
Payment for immunosuppression after organ transplantation. American Society of Transplantation. JAMA (2000) 1.52
Repeat organ transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.50
Transplant data: sources, collection and research considerations, 2004. Am J Transplant (2005) 1.22
Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis (1990) 1.21
Kidney transplantation and wait-listing rates from the international Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int (2005) 1.20
Patterns of care for patients with chronic kidney disease in the United States: dying for improvement. J Am Soc Nephrol (2003) 1.19
Late renal allograft failure between 1990 and 1998 in Spain: a changing scenario. Transplantation (2003) 1.12
Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3-year randomized, multicenter, phase III study. Transplantation (2005) 1.12
Medical care of kidney transplant recipients after the first posttransplant year. Clin J Am Soc Nephrol (2006) 1.05
Recent developments in kidney transplantation--a critical assessment. Am J Transplant (2009) 1.02
The influence of hepatitis B and hepatitis C virus infection in the recipient on late renal allograft failure. Nephrol Dial Transplant (2004) 0.92
Who is caring for kidney transplant patients? Variation by region, transplant center, and patient characteristics. Am J Nephrol (2009) 0.86
Long-term management of the renal transplant recipient: optimizing the relationship between the transplant center and the community nephrologist. Am J Kidney Dis (2001) 0.84
[Dialysis and transplantation report of the Spanish Nephrology Society and Autonomous Registries for the year 2000]. Nefrologia (2002) 0.83
1997 spanish nephrology association (Sociedad Española de nefrologia) report on dialysis and transplantation. Nephrol Dial Transplant (1999) 0.80
Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology (2003) 10.11
Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med (2003) 8.47
A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation (2009) 4.45
Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients. Transplantation (2007) 3.69
Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation (2002) 3.42
Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology (2007) 2.72
Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg (2005) 2.64
High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol (2013) 2.62
Expanded criteria donors for kidney transplantation. Am J Transplant (2003) 2.25
Rates of solid-organ wait-listing, transplantation, and survival among residents of rural and urban areas. JAMA (2008) 2.24
Improving liver allocation: MELD and PELD. Am J Transplant (2004) 2.14
Hyperinsulinemia and hyperfiltration in renal transplantation. Transplantation (2009) 2.06
Haemodialysis using high cut-off dialysers for treating acute renal failure in multiple myeloma. Nefrologia (2012) 2.06
Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology (2011) 2.01
Racial and ethnic disparities in access to liver transplantation. Liver Transpl (2010) 1.94
Association of center volume with outcome after liver and kidney transplantation. Am J Transplant (2004) 1.92
Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. Am J Transplant (2004) 1.90
Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit. Hepatology (2009) 1.84
Re-weighting the model for end-stage liver disease score components. Gastroenterology (2008) 1.83
Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates. Transplantation (2003) 1.79
Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol (2008) 1.76
Serum sodium and survival benefit of liver transplantation. Liver Transpl (2015) 1.75
Influence of graft type on outcomes after pediatric liver transplantation. Am J Transplant (2004) 1.72
A novel risk score for mortality in renal transplant recipients beyond the first posttransplant year. Transplantation (2009) 1.72
Effect of body mass index on the survival benefit of liver transplantation. Liver Transpl (2007) 1.69
Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients. Transplantation (2006) 1.68
Calcium-mediated parathyroid hormone release changes in patients treated with the calcimimetic agent cinacalcet. Nephrol Dial Transplant (2008) 1.60
Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2011) 1.59
Early subclinical rejection as a risk factor for late chronic humoral rejection. Transplantation (2012) 1.52
Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Nephrol Dial Transplant (2005) 1.50
Valganciclovir preemptive therapy for the prevention of cytomegalovirus disease in high-risk seropositive solid-organ transplant recipients. Transplantation (2006) 1.49
Hepatitis C is a risk factor for death after liver retransplantation. Liver Transpl (2005) 1.48
Satisfaction With Life Among Living Kidney Donors: A RELIVE Study of Long-Term Donor Outcomes. Transplantation (2014) 1.45
Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant (2002) 1.44
Antibody-mediated rejection: analyzing the risk, proposing solutions. Transplantation (2014) 1.44
Low serum mannose-binding lectin as a risk factor for new onset diabetes mellitus after renal transplantation. Transplantation (2009) 1.44
Predictive factors of allosensitization in renal transplant patients switched from calcineurin to mTOR inhibitors. Transpl Int (2014) 1.43
Portal vein thrombosis and liver transplant survival benefit. Liver Transpl (2010) 1.42
Late evolution of kidney transplants in elderly donors and recipients receiving initial immunosuppressant treatment with daclizumab, mycophenolate mofetil, and delayed introduction of tacrolimus. Nefrologia (2012) 1.39
Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial. Nephrol Dial Transplant (2003) 1.39
An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document. Nefrologia (2013) 1.37
Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial. Am J Transplant (2005) 1.37
Outcomes of donor evaluation in adult-to-adult living donor liver transplantation. Hepatology (2007) 1.31
Simulating the allocation of organs for transplantation. Health Care Manag Sci (2004) 1.31
New-onset diabetes after kidney transplantation: risk factors. J Am Soc Nephrol (2006) 1.28
Epidemiology of regular prescribed opioid use: results from a national, population-based survey. J Pain Symptom Manage (2008) 1.24
Extracorporeal support for organ donation after cardiac death effectively expands the donor pool. J Trauma (2005) 1.22
Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial. Crit Care (2007) 1.22
Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant (2002) 1.21
Kidney transplantation and wait-listing rates from the international Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int (2005) 1.20
End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates. Hepatology (2011) 1.19
Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl (2004) 1.19
Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol (2008) 1.15
The report of a national conference on the wait list for kidney transplantation. Am J Transplant (2003) 1.14
Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study. Transplantation (2011) 1.13
Late renal allograft failure between 1990 and 1998 in Spain: a changing scenario. Transplantation (2003) 1.12
Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years. Am J Transplant (2004) 1.12
Estimation of total glomerular number in stable renal transplants. J Am Soc Nephrol (2003) 1.10
New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression. Transplantation (2011) 1.10
Impact of the expanded criteria donor allocation system on the use of expanded criteria donor kidneys. Transplantation (2005) 1.10
Epithelioid hemangioendothelioma of the liver disseminated to the peritoneum treated with liver transplantation and interferon alpha-2B. Transplantation (2002) 1.09
Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study. Ann Surg (2008) 1.09
Outcomes of adult living donor liver transplantation: comparison of the Adult-to-adult Living Donor Liver Transplantation Cohort Study and the national experience. Liver Transpl (2011) 1.09
Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates. J Immunol (2007) 1.08
Effect of pretransplant serum creatinine on the survival benefit of liver transplantation. Liver Transpl (2009) 1.06
ImmuKnow as a diagnostic tool for predicting infection and acute rejection in adult liver transplant recipients: a systematic review and meta-analysis. Liver Transpl (2012) 1.05
Successful treatment of mucor infection after liver or pancreas-kidney transplantation. Transplantation (2002) 1.04
Patient-specific prediction of ESRD after liver transplantation. J Am Soc Nephrol (2013) 1.04
Cholesterol embolism: still an unrecognized entity with a high mortality rate. J Am Acad Dermatol (2006) 1.03
Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? Kidney Int (2009) 1.03
Are primary care services a substitute or complement for specialty and inpatient services? Health Serv Res (2005) 1.03
Selection of pediatric candidates under the PELD system. Liver Transpl (2004) 1.01
Thoracic organ transplantation in the United States, 1994-2003. Am J Transplant (2005) 1.00
Inhibition of B cell death causes the development of an IgA nephropathy in (New Zealand white x C57BL/6)F(1)-bcl-2 transgenic mice. J Immunol (2004) 1.00
Educational web-based intervention for high school students to increase knowledge and promote positive attitudes toward organ donation. Health Educ Behav (2006) 1.00
Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone. Clin J Am Soc Nephrol (2013) 0.99
Gender imbalance and outcomes in living donor renal transplantation in the United States. Am J Transplant (2003) 0.99
Use of proliferation signal inhibitors in the management of post-transplant malignancies--clinical guidance. Nephrol Dial Transplant (2007) 0.99
Impact of the expanded criteria donor allocation system on candidates for and recipients of expanded criteria donor kidneys. Transplantation (2007) 0.99
Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies. Kidney Int (2002) 0.99
Acute graft pyelonephritis in renal transplant recipients: incidence, risk factors and long-term outcome. Nephrol Dial Transplant (2010) 0.99
The triple threat for chronic disease: obesity, race, and depression. Psychosomatics (2006) 0.98
Novel views on new-onset diabetes after transplantation: development, prevention and treatment. Nephrol Dial Transplant (2013) 0.97
Gender imbalance in living donor renal transplantation. Transplantation (2002) 0.97
Pleural effusion secondary to minoxidil in a peritoneal dialysis patient. Nephrol Dial Transplant (2004) 0.95
Survival benefit of kidney and liver transplantation for obese patients on the waiting list. Clin Transpl (2003) 0.95
Creatinine reduction ratio on post-transplant day two as criterion in defining delayed graft function. Am J Transplant (2004) 0.95
Henoch-Schönlein purpura in northern Spain: clinical spectrum of the disease in 417 patients from a single center. Medicine (Baltimore) (2014) 0.94
Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study. Nephrol Dial Transplant (2012) 0.94
The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy. Nephrol Dial Transplant (2009) 0.93